Sort
21,281 grants matching “influenza”
Antigenic Drift in Influenza A Virus
$248,901Jonathan W Yewdell · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Biology and Pathogenesis of Influenza A Virus
$248,901Jack R Bennink · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Human and Tuberculin CoA Biosynthetic Enzyme Structures
$248,898Tina Izard · Scripps Research Institute, The · R01 · FY2007 · AI
Mechanism of membrane inactivation method to prepare enveloped virus vaccines
$248,896Hector Aguilar-Carreno · Cornell University · R21 · FY2021 · AI
Comparative Effectiveness Research on Hospital Readmissions for COPD
$248,875Carlos A. Camargo · Massachusetts General Hospital · R01 · FY2018 · HS
INTERMEDIATES AND TRANSBILAYER PEPTIDES
$248,873Ohio State University · R01 · FY2000 · GM
5 YEAR STRATEGY FOR REDUCING MORBIDITY & MORTALITY CAUSED BY INFLUENZA
$248,851Caroline Brown · World Health Organization · U51 · FY2013 · IP
Rejuvenating aged T cell immunity by targeting stem cell-like CD8 T cells
$248,826Tuoqi Wu · University Of Colorado Denver · R00 · FY2019 · AG
In Vivo Cluster AI Prediction (CLAIRE) of COVID-19 Disease Progression
$248,723Patricia Buendia · Lifetime Omics, Inc. · R43 · FY2021 · EB
Emerging Infectious Diseases Training Program
$248,693Kathleen A. McDonough · Wadsworth Center · T32 · FY2014 · AI
Empirical space-time evaluation of priority groups for influenza control
$248,684John S. Brownstein · Boston Children'S Hospital · R21 · FY2008 · AI
Improving the design and statistical analysis of cluster-randomized trials on tropical infectious diseases
$248,648Bingkai Wang · University Of Michigan At Ann Arbor · R00 · FY2025 · AI
Improving the design and statistical analysis of cluster-randomized trials on tropical infectious diseases
$248,648Bingkai Wang · University Of Michigan At Ann Arbor · R00 · FY2024 · AI
Reversing aging-induced lymphatic dysfunction to improve immune function
$248,600Timothy P Padera · Massachusetts General Hospital · R21 · FY2022 · AG
Inflammatory Dendritic Cells in Influenza Virus Infection
$248,570Thomas M Moran · Icahn School Of Medicine At Mount Sinai · R21 · FY2007 · AI
INTRODUCING THE USE OF SEASONAL INFLUENZA VACCINE IN PUBLIC HEALTH
$248,556Julius Lutwaama · Uganda Virus Research Institute · U51 · FY2014 · IP
Delivery and Adjuvantation of Nicotine Vaccine by Laser Illumination
$248,521Xinyuan Chen · University Of Rhode Island · R00 · FY2015 · DA
Dissecting ADP-ribosylation as an innate immune response countering influenza virus replication
$248,446Andrew Mehle · University Of Wisconsin-Madison · R21 · FY2021 · AI
Enhanced Live Attenuated Influenza Virus With Improved Safety and Immunogenicity
$248,425Stephen Dewhurst · University Of Rochester · R21 · FY2015 · AI
Integrative Multi-Scale Systems Analysis of Gene-Expression-Driven Aging Morbidity
$248,412Thomas Stoeger · Northwestern University · R00 · FY2024 · AG
Recognition of cross-reactive antigens by human CD4+ T cells
$248,400Jun Huang · University Of Chicago · R00 · FY2016 · AI
INTRODUCTION OF SEASONAL INFLUENZA VACCINATION IN KENYA
$248,350William Maina · Kenya Ministry/Public Hlth & Sanitation · U51 · FY2013 · IP
INTRODUCTION OF SEASONAL INFLUENZA VACCINATION IN KENYA
$248,350Jackson Kioko · Kenya Ministry/Public Hlth & Sanitation · U51 · FY2014 · IP
Surfactant Lipid and Protein Inhibition of Rhinovirus Infections
$248,308Dennis R Voelker · University Of Arizona · U19 · FY2023 · AI
M2-BASED INFLUENZA TYPE A VIRUS VACCINE
$248,276Wistar Institute · R01 · FY2003 · AI